322 related articles for article (PubMed ID: 18820709)
1. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.
von Bonin M; Stölzel F; Goedecke A; Richter K; Wuschek N; Hölig K; Platzbecker U; Illmer T; Schaich M; Schetelig J; Kiani A; Ordemann R; Ehninger G; Schmitz M; Bornhäuser M
Bone Marrow Transplant; 2009 Feb; 43(3):245-51. PubMed ID: 18820709
[TBL] [Abstract][Full Text] [Related]
2. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
Lucchini G; Introna M; Dander E; Rovelli A; Balduzzi A; Bonanomi S; Salvadè A; Capelli C; Belotti D; Gaipa G; Perseghin P; Vinci P; Lanino E; Chiusolo P; Orofino MG; Marktel S; Golay J; Rambaldi A; Biondi A; D'Amico G; Biagi E
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1293-301. PubMed ID: 20350611
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Ringdén O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lönnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Transplantation; 2006 May; 81(10):1390-7. PubMed ID: 16732175
[TBL] [Abstract][Full Text] [Related]
4. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
[TBL] [Abstract][Full Text] [Related]
5. Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
Sánchez-Guijo F; Caballero-Velázquez T; López-Villar O; Redondo A; Parody R; Martínez C; Olavarría E; Andreu E; Prósper F; Díez-Campelo M; Regidor C; Villaron E; López-Corral L; Caballero D; Cañizo MC; Pérez-Simon JA
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1580-5. PubMed ID: 24952358
[TBL] [Abstract][Full Text] [Related]
6. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
[TBL] [Abstract][Full Text] [Related]
10. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease.
Fang B; Song Y; Liao L; Zhang Y; Zhao RC
Transplant Proc; 2007 Dec; 39(10):3358-62. PubMed ID: 18089385
[TBL] [Abstract][Full Text] [Related]
11. [Clinical observation of mesenchymal stem cell as salvage treatment for refractory acute graft-versus-host disease].
Zhao K; Huang F; Peng YW; Zhou HS; Fan ZP; Zhang X; Guo XT; Xu N; Sun J; Xiang P; Liu QF
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):122-6. PubMed ID: 23611218
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.
Prasad VK; Lucas KG; Kleiner GI; Talano JA; Jacobsohn D; Broadwater G; Monroy R; Kurtzberg J
Biol Blood Marrow Transplant; 2011 Apr; 17(4):534-41. PubMed ID: 20457269
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
[TBL] [Abstract][Full Text] [Related]
15. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
[TBL] [Abstract][Full Text] [Related]
16. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.
Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Alwayn IP; Weimar W; Hoogduijn MJ
Transplantation; 2009 Mar; 87(6):896-906. PubMed ID: 19300194
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.
von Dalowski F; Kramer M; Wermke M; Wehner R; Röllig C; Alakel N; Stölzel F; Parmentier S; Sockel K; Krech M; Schmitz M; Platzbecker U; Schetelig J; Bornhäuser M; von Bonin M
Stem Cells; 2016 Feb; 34(2):357-66. PubMed ID: 26418955
[TBL] [Abstract][Full Text] [Related]
18. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum.
Le Blanc K; Samuelsson H; Lönnies L; Sundin M; Ringdén O
Transplantation; 2007 Oct; 84(8):1055-9. PubMed ID: 17989613
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.
Wu KH; Chan CK; Tsai C; Chang YH; Sieber M; Chiu TH; Ho M; Peng CT; Wu HP; Huang JL
Transplantation; 2011 Jun; 91(12):1412-6. PubMed ID: 21494176
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Jones BJ; McTaggart SJ
Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
